April 14 2023: Given the presence of 1-boc-4-(4-fluorophenylamino)piperidine in this sample, the remaining unidentified analyte might be boc-p-fluoronorfentanyl, which would be part of a protecting strategy towards making 4-fluorofentanyl and fentanyl. (Thank you to K. for this identification.)
July 19 2022: The 1-boc-4-(4-fluorophenylamino)piperidine was initially unidentified, but has been established by library match.
There is no laboratory reference standard available as of July 19, 2022 to confirm this identification.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.
Unidentified Substance #2: 20 parts (now tentatively identified, see below)
July 19 2022: The 1-boc-4-(4-fluorophenylamino)piperidine was initially unidentified, but has been established by library match.
There is no laboratory reference standard available as of July 19, 2022 to confirm this identification.